BioAge Labs BIOA
NASDAQ BIOA
$9.17 -0.23 (-2.40%)
As of: Sep 9, 2026 · 3:59 PM EDT

BioAge Labs (BIOA) EPS (Basic) (2023 - 2026)

BioAge Labs' (BIOA) quarterly EPS (Basic) came in at -$0.58 in Q2 2026, up 3.93% year-over-year from -$0.56 in Q2 2025, and down 10.78% quarter-over-quarter from -$0.52 in Q1 2026.

Analysis

BioAge Labs (BIOA) EPS (Basic) (2023 - 2026) Analysis & Trends

BioAge Labs has disclosed EPS (Basic) across 4 years of filings, most recently posting -$0.58 for Q2 2026.

  • In Q2 2026, EPS (Basic) rose 3.93% year-over-year to -$0.58; the TTM figure through Jun 2026 stood at -$2.09 (up 5.24% YoY), while the FY2025 annual figure was -$2.24, up 66.17% from the prior year.
  • EPS (Basic) came in at -$0.58 for Q2 2026 at BioAge Labs, down from -$0.52 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.36 in Q1 2025 to a low of -$9.43 in Q4 2023.
  • Average EPS (Basic) over 4 years is -$3.66, with a median of -$1.36 recorded in 2024.
  • Year-over-year, EPS (Basic) jumped 95.24% in 2025 and sank 43.91% in 2026.
  • Over 4 years, EPS (Basic) stood at -$9.43 in 2023, then jumped by 78.66% to -$2.01 in 2024, then surged by 64.43% to -$0.72 in 2025, then increased by 19.32% to -$0.58 in 2026.
  • Per Business Quant data, the three most recent EPS (Basic) figures were -$0.58 in Q2 2026, -$0.52 in Q1 2026, and -$0.72 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 4.40
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -8.44
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 4.34
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 12.62
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 7.70
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -1.96
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.23
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 0.66
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -0.40
10 BioAge Labs 409.83 Mn 409.83 Mn -14.23 Mn -0.58
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.58
Mar 31, 2026 -0.52
Dec 31, 2025 -0.72
Sep 30, 2025 -0.56
Jun 30, 2025 -0.60
Mar 31, 2025 -0.36
Dec 31, 2024 -2.01
Sep 30, 2024 -6.61
Jun 30, 2024 -7.90
Mar 31, 2024 -7.61
Dec 31, 2023 -9.43
Sep 30, 2023 -7.05